HLB Co., Ltd. (028300.KQ)
KRW 70500.0
(-1.26%)
KRW 70500.0
(-1.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 17.93 Billion KRW | 5504.13% |
| 2022 | 320 Million KRW | -99.32% |
| 2021 | 47.37 Billion KRW | 7616.34% |
| 2020 | 613.99 Million KRW | -99.18% |
| 2019 | 74.52 Billion KRW | 69.31% |
| 2018 | 44.01 Billion KRW | 918.89% |
| 2017 | 4.32 Billion KRW | -28.67% |
| 2016 | 6.05 Billion KRW | 12.71% |
| 2015 | 5.37 Billion KRW | -36.07% |
| 2014 | 8.4 Billion KRW | 367.77% |
| 2013 | 1.79 Billion KRW | -35.08% |
| 2012 | 2.76 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 76.81 Billion KRW | 328.36% |
| 2024 Q2 | 56.34 Billion KRW | -26.65% |
| 2023 Q3 | 16.61 Billion KRW | 4.81% |
| 2023 Q2 | 15.85 Billion KRW | 1.14% |
| 2023 FY | 17.93 Billion KRW | 5504.13% |
| 2023 Q1 | 15.67 Billion KRW | 4799.42% |
| 2023 Q4 | 17.93 Billion KRW | 7.91% |
| 2022 Q4 | 320 Million KRW | -99.63% |
| 2022 Q3 | 86.83 Billion KRW | 3.17% |
| 2022 Q2 | 84.16 Billion KRW | 72.43% |
| 2022 Q1 | 48.81 Billion KRW | 3.03% |
| 2022 FY | 320 Million KRW | -99.32% |
| 2021 Q4 | 47.37 Billion KRW | 2978.55% |
| 2021 Q2 | 1.49 Billion KRW | 1.51% |
| 2021 FY | 47.37 Billion KRW | 7616.34% |
| 2021 Q1 | 1.47 Billion KRW | -84.23% |
| 2021 Q3 | 1.53 Billion KRW | 2.86% |
| 2020 Q1 | 63.07 Billion KRW | -16.4% |
| 2020 FY | 613.99 Million KRW | -99.18% |
| 2020 Q2 | 39.05 Billion KRW | -38.08% |
| 2020 Q3 | 2.02 Billion KRW | -94.82% |
| 2020 Q4 | 9.34 Billion KRW | 362.04% |
| 2019 Q1 | 53.88 Billion KRW | 22.42% |
| 2019 Q2 | 49.84 Billion KRW | -7.5% |
| 2019 FY | 74.52 Billion KRW | 69.31% |
| 2019 Q4 | 75.45 Billion KRW | 46.32% |
| 2019 Q3 | 51.56 Billion KRW | 3.45% |
| 2018 Q1 | 9.98 Billion KRW | 131.04% |
| 2018 Q4 | 44.01 Billion KRW | 31.82% |
| 2018 Q3 | 33.39 Billion KRW | 22.9% |
| 2018 Q2 | 27.16 Billion KRW | 172.21% |
| 2018 FY | 44.01 Billion KRW | 918.89% |
| 2017 Q4 | 4.32 Billion KRW | -62.24% |
| 2017 FY | 4.32 Billion KRW | -28.67% |
| 2017 Q1 | 6.2 Billion KRW | 2.51% |
| 2017 Q2 | 11.14 Billion KRW | 79.58% |
| 2017 Q3 | 11.43 Billion KRW | 2.6% |
| 2016 Q3 | 5.92 Billion KRW | 5.17% |
| 2016 FY | 6.05 Billion KRW | 12.71% |
| 2016 Q4 | 6.05 Billion KRW | 2.22% |
| 2016 Q2 | 5.63 Billion KRW | 2.36% |
| 2016 Q1 | 5.5 Billion KRW | 2.42% |
| 2015 Q1 | 8.84 Billion KRW | 5.26% |
| 2015 Q4 | 5.37 Billion KRW | 0.0% |
| 2015 FY | 5.37 Billion KRW | -36.07% |
| 2015 Q2 | - KRW | -100.0% |
| 2015 Q3 | - KRW | 0.0% |
| 2014 Q4 | 8.4 Billion KRW | 22.55% |
| 2014 Q3 | 6.85 Billion KRW | 1.83% |
| 2014 Q2 | 6.73 Billion KRW | 2.23% |
| 2014 Q1 | 6.58 Billion KRW | 266.67% |
| 2014 FY | 8.4 Billion KRW | 367.77% |
| 2013 Q4 | 1.79 Billion KRW | -9.15% |
| 2013 FY | 1.79 Billion KRW | -35.08% |
| 2013 Q1 | 4.36 Billion KRW | 57.62% |
| 2013 Q3 | 1.97 Billion KRW | -51.31% |
| 2013 Q2 | 4.06 Billion KRW | -6.88% |
| 2012 Q4 | 2.76 Billion KRW | 0.0% |
| 2012 FY | 2.76 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| iNtRON Biotechnology, Inc. | 258.29 Million KRW | -6842.926% |
| BINEX Co., Ltd. | 5.57 Billion KRW | -221.479% |
| Bioneer Corporation | 12.5 Billion KRW | -43.466% |
| Anterogen.Co.,Ltd. | - KRW | -Infinity% |
| MEDIPOST Co., Ltd. | 6.99 Billion KRW | -156.375% |
| CrystalGenomics, Inc. | 29.88 Billion USD | 40.001% |
| Helixmith Co., Ltd | 151.68 Million KRW | -11723.062% |
| Chabiotech Co.,Ltd. | 95.06 Billion KRW | 81.136% |
| Medy-Tox Inc. | 1.22 Billion KRW | -1362.931% |
| Peptron, Inc. | 4.5 Billion KRW | -298.516% |
| Amicogen, Inc. | 70.65 Billion KRW | 74.618% |
| Genexine, Inc. | 22.68 Billion KRW | 20.934% |
| HLB Therapeutics Co.,Ltd. | 1.84 Billion KRW | -874.531% |
| LegoChem Biosciences, Inc. | 528.37 Million KRW | -3294.048% |
| ALTEOGEN Inc. | 1.24 Billion KRW | -1335.511% |
| PharmaResearch Co., Ltd. | 970.71 Million KRW | -1747.42% |
| SillaJen, Inc. | 8.13 Billion KRW | -120.422% |
| JETEMA, Co., Ltd. | 60 Billion KRW | 70.111% |
| OliX Pharmaceuticals,Inc | 35.36 Billion KRW | 49.286% |
| Genomictree Inc. | 97.51 Million KRW | -18290.094% |
| MedPacto, Inc. | 1.68 Billion KRW | -963.058% |
| D&D Pharmatech | 5.12 Billion KRW | -250.216% |
| EASY BIO,Inc. | 30 Billion KRW | 40.223% |
| GI Innovation, Inc. | 2.9 Billion KRW | -517.534% |